References
- WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it: World Health Organization (WHO). Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed 810, 2020.
- WHO. Novel Coronavirus – china [Internet]; 2020 Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 810, 2020.
- WHO. Coronavirus disease (COVID-19) outbreak situation. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situationreports/20200409-sitrep-80-covid-19.pdf?sfvrsn=1b685d64_2.
- Wiseman AC. Immunosuppressive medications. Clin J Am Soc Nephrol. 2016;11(2):332–343. doi:10.2215/CJN.0857081426170177
- Shrestha R, Shrestha S, Khanal P, Kc B. Nepal’s first case of COVID-19 and public health response. J Travel Med. 2020;27(3):taaa024. doi:10.1093/jtm/taaa02432104884
- Piryani RM, Piryani S, Shah JN. Nepal’s response to contain COVID-19 infection. J Nepal Health Res Counc. 2020;18(1):128–134. doi:10.33314/jnhrc.v18i1.260832335608
- Zhong BL, Luo W, Li HM, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745–1752. doi:10.7150/ijbs.4522132226294
- Crawford SD, Couper MP, Lamias MJ. Web surveys: perceptions of burden. Soc Sci Comput Rev. 2001;19(2):146–162. doi:10.1177/089443930101900202
- Asim M, Sathian B, van Teijlingen E, Mekkodathil A, Subramanya SH, Simkhada P. COVID-19 pandemic: public health implications in Nepal. Nepal J Epidemiol. 2020;10(1):817–820. doi:10.3126/nje.v10i1.2826932257511
- Nepal telecommunications authority. MIS report [Internet]. Kathmandu; 2019 Available from: https://nta.gov.np/en/mis-reports/. Accessed 810, 2020.
- Kathmandupost. At Covid-19 helpline, thousands of calls from Nepalis looking for accurate information. 2020/3/17; 2020 Available from: https://kathmandupost.com/national/2020/03/17/at-covid-19-helpline-thousands-of-calls-from-nepalis-looking-for-accurate-information. Accessed 82, 2020.
- WHO. covid19nepal; 2020 Available from: https://www.who.int/nepal/covid19nepal. Accessed 82, 2020.
- Tam L-S, Tanaka Y, Handa R, et al. Care for patients with rheumatic diseases during COVID-19 pandemic: a position statement from APLAR. Int J Rheum Dis. 2020;23(6):717–722. doi:10.1111/1756-185X.1386332462761
- Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-032020029
- Parperis K. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic. Ann Rheum Dis. 2020;annrheumdis-2020-217557.
- UNLo M A study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia (COVACTA); 2020 Available from: https://clinicaltrials.gov/ct2/show/NCT04320615. Accessed 810, 2020.
- Papachristodoulou E, Kakoullis L, Parperis K, Panos G. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge. Pathog Dis. 2020;78(3). doi:10.1093/femspd/ftaa025